NCT01224730View on ClinicalTrials.gov

A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 24, 2012

Primary Completion Date

November 4, 2013

Study Completion Date

November 4, 2013

Conditions

Cancer

Interventions

DRUG

perifosine

100 mg daily

Trial Locations (2)

75230

Dallas

77030

Houston

Sponsors

Lead Sponsor

AEterna Zentaris

All Listed Sponsors

lead

AEterna Zentaris

INDUSTRY

NCT01224730 - A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies | Biotech Hunter | Biotech Hunter